Crypto has entered a new phase following the introduction of spot ETFs. Derivatives have displaced spot as the primary locus ...

Maharashtra continues to hold a dominant share of India’s data-centre stock, backed by favourable policy, strong ...

Financing co-led by GordonMD Global Investments® LP and M VenturesCompany rebrands from EG 427 to Cyllene Therapeutics Paris, July 07, 2026 ...

Bioventus stock is upgraded to a "Buy" amid a breakout driven by favorable regulatory developments. Here's what investors ...

Following the autopsy, the theory that has gained most weight is that of a “suicide attempt”, according to the Guardia Civil ...

Specialised excavator attachments are turning these machines multi-functional, helping contractors maximise utilisation and minimise fleet complexity. A report.. Excavator attachments: One machine, ...

CMS wants to send even more surgical volume ASCs’ way — and some leaders think their case lists are about to grow relatively quickly. The agency proposed a rule July 2 that would revise Medicare ...

As Islamic finance moves into the mainstream, Maybank helps clients connect wealth, business and legacy needs across Asean ...

For the past decade, we’ve been sold a seductive vision: the “smart city.” Gleaming control rooms, traffic lights that talk ...

Applied Biologics, a biopharmaceutical company advancing novel biologic therapies for serious diseases with significant unmet medical needs, today announced an expanded strategic initiative focused on ...

As an original equipment manufacturer (OEM) with a dedicated research and development team, over 100 core patents, and a high-capacity 5,000-square-meter manufacturing facility, the company operates ...

Cyllene Therapeutics ("Cyllene"), formerly known as EG 427, today announced the closing of a €33 million Series C financing ...